INTERCEPT PHARMACEUTICALS, INC. Insider Trading for November 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INTERCEPT PHARMACEUTICALS, INC. for November 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 21.50 | 31 | 667 | 51,891 | |
| Nov 20 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 6,685 | 57,937 | 36,314 | |
| Nov 20 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 21.50 | 31 | 667 | 486,625 | 486.6 K to 486.6 K (+0.01 %) |
| Nov 20 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 6,685 | 57,937 | 486,594 | 479.9 K to 486.6 K (+1.39 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Option Exercise | M | 10.40 | 4,000 | 41,600 | 10,703 | |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 160.30 | 502 | 80,471 | 14,065 | 14.6 K to 14.1 K (-3.45 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 159.62 | 1,698 | 271,038 | 14,567 | 16.3 K to 14.6 K (-10.44 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 158.45 | 1,590 | 251,939 | 16,265 | 17.9 K to 16.3 K (-8.91 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Sell | S | 157.28 | 1,000 | 157,283 | 17,855 | 18.9 K to 17.9 K (-5.30 %) |
| Nov 19 2014 | ICPT | INTERCEPT PHARMACE ... | Shapiro David | CMO and EVP - Devel ... | Buy | M | 10.40 | 4,000 | 41,600 | 18,855 | 14.9 K to 18.9 K (+26.93 %) |
| Nov 13 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 21.50 | 2,500 | 53,750 | 6,249 | |
| Nov 13 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 163.27 | 500 | 81,634 | 7,642 | 7.1 K to 7.6 K (+7.00 %) |
| Nov 13 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 173.67 | 1,000 | 173,665 | 7,142 | 6.1 K to 7.1 K (+16.28 %) |
| Nov 13 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | P | 158.18 | 500 | 79,088 | 6,142 | 5.6 K to 6.1 K (+8.86 %) |
| Nov 13 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 21.50 | 2,500 | 53,750 | 5,642 | 3.1 K to 5.6 K (+79.57 %) |
| Nov 12 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Option Exercise | M | 21.50 | 233 | 5,010 | 10,867 | |
| Nov 12 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Sell | S | 175.95 | 233 | 40,996 | 2,166 | 2.4 K to 2.2 K (-9.71 %) |
| Nov 12 2014 | ICPT | INTERCEPT PHARMACE ... | VEITINGER KLAUS R DR | Director | Buy | M | 21.50 | 233 | 5,010 | 2,399 | 2.2 K to 2.4 K (+10.76 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Option Exercise | M | 0.00 | 324 | 0 | 0 | |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | AKKARAJU SRINIVAS | Director | Buy | M | 0.00 | 324 | 0 | 3,142 | 2.8 K to 3.1 K (+11.50 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Option Exercise | M | 8.67 | 10,000 | 86,667 | 146,628 | |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 262.46 | 500 | 131,231 | 479,909 | 480.4 K to 479.9 K (-0.10 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 261.71 | 2,950 | 772,034 | 480,409 | 483.4 K to 480.4 K (-0.61 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 260.68 | 3,166 | 825,300 | 483,359 | 486.5 K to 483.4 K (-0.65 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 259.47 | 1,100 | 285,420 | 486,525 | 487.6 K to 486.5 K (-0.23 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 257.96 | 400 | 103,184 | 487,625 | 488 K to 487.6 K (-0.08 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 256.54 | 200 | 51,308 | 488,025 | 488.2 K to 488 K (-0.04 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 255.30 | 300 | 76,589 | 488,225 | 488.5 K to 488.2 K (-0.06 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 254.29 | 500 | 127,146 | 488,525 | 489 K to 488.5 K (-0.10 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 252.90 | 300 | 75,870 | 489,025 | 489.3 K to 489 K (-0.06 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 250.80 | 384 | 96,308 | 489,325 | 489.7 K to 489.3 K (-0.08 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 249.69 | 100 | 24,969 | 489,709 | 489.8 K to 489.7 K (-0.02 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Sell | S | 247.66 | 100 | 24,766 | 489,809 | 489.9 K to 489.8 K (-0.02 %) |
| Nov 05 2014 | ICPT | INTERCEPT PHARMACE ... | Pruzanski Mark | CEO & President | Buy | M | 8.67 | 10,000 | 86,667 | 489,909 | 479.9 K to 489.9 K (+2.08 %) |